Clinical Studies Groups
The DeNDRoN Clinical Studies Groups (CSGs) represent a central component of a new framework for neurodegeneration research in the UK, providing the primary route through which the portfolio will be developed.
The CSGs are charged with the development of a portfolio of national multi-centre and local/pilot clinical trials and other well-designed studies. The CSGs work to a broad, but common remit that includes overseeing existing studies, considering new research questions, developing proposals and securing funding from CRC partners, as well as providing expert advice. Each of the CSGs is formally constituted, with a system of membership rotation and a transparent appointment process for new Chairs.
The CSGs are:
Dementias
Chaired by Professor Cornelius Katona, University College London
Parkinson's Disease
Chaired by Professor David Burn, Newcastle University
Motor Neurone Disease
Chaired by Professor Pamela Shaw, University of Sheffield
Clinical Research Methodology
Chaired by Professor John Zajicek, Peninsula Medical School
Chaired by Professor Cornelius Katona, University College London
Parkinson's Disease
Chaired by Professor David Burn, Newcastle University
Motor Neurone Disease
Chaired by Professor Pamela Shaw, University of Sheffield
Clinical Research Methodology
Chaired by Professor John Zajicek, Peninsula Medical School
Huntington's Disease
Chaired by Professor Anne Rosser, Cardiff University
Primary Care
Chaired by Professor Steve Iliffe, University College London
Neuropathology & Brain Banking
Chaired by Professor Paul Ince, University of Sheffield
Chaired by Professor Anne Rosser, Cardiff University
Primary Care
Chaired by Professor Steve Iliffe, University College London
Neuropathology & Brain Banking
Chaired by Professor Paul Ince, University of Sheffield